Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Chuangjian Pharmaceutical, often operating under the brand Trautec, is a leading Chinese biotechnology company focused on synthetic biology and recombinant humanized collagen. The company specializes in the R&D and large-scale manufacturing of various collagen types, including Type I, II, III, and XVII, which are used in medical aesthetics, wound care, and regenerative medicine. By utilizing advanced fermentation and purification processes, Hebei Chuangjian produces collagen that is highly biocompatible and identical to human protein sequences. Their products are widely used in medical devices, professional skincare, and as raw materials for global pharmaceutical and cosmetic brands. The company is recognized for its significant contributions to the standardization of recombinant collagen in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Chuangjian Pharmaceutical.